As the demand for app-based services grows, now may be the time to invest in UX research to identify needed improvements and enhancements.
Back to team page
Shelly Holbrook
Director
Shelly has worked on complex human factors research problems for 10+ years in a variety of industries, with projects spanning the entire product lifecycle from inception to market. Her training in industrial and systems engineering has provided her the necessary skillset to evaluate both the human and technical components of systems to create intuitive, optimal solutions. Shelly has experience with both qualitative and quantitative research methods, specializing in formative and summative usability testing. Her work in community pharmacy health IT system development, in conjunction with electronic health record implementation, and device and software development in diabetes care has earned her multiple publications. Shelly has a MS and PhD in Industrial Engineering with a Human Factors research emphasis from Purdue University and a BS in Industrial Engineering from Clemson University.
Bold facts
Learn more about
Something unique about you summed up in one sentence
Your favorite part of working at Bold Insight
In your spare time (or if you had spare time), you would absolutely do this:
How long have you been in the UX field?
You cannot start the day without doing this…
Your favorite city in the world is...and why?
Your ultimate celebrity dinner party guest list would include:
Long-term personal or professional goal?
- Unlocking the power of user-centric design for business success
- Bold Insight to present on IFU design, digital telemetry, and other human factors topics at HFES Healthcare Symposium
- Improve medical device safety with these packaging design tips
- Bold Insight to present on global medical device testing, in-person research logistics during COVID at HFES Health Care Symposium
- Working from home: Tips for designing your workspace from an ergonomics expert
Read our team’s latest bold insights
Human factors research in the times of COVID
Human factors research in the support of medical and drug delivery device commercialization is essential and we should be planning on a return to in-person research as soon as is possible by applying all available and practical protective measures.
COVID-19: Using human factors and UX to make a positive impact
We have aggregated some considerations for HCPs, healthcare organizations, and others involved in the medical space.
Is FMEA inadequate for human factors analyses?
A “traditional” risk assessment does not meet the needs of FDA-required human factors analyses.